Our focus from the very beginning has been on two fronts – advancing microalgae cultivation technologies from flasks to commercial scale and innovating downstream extraction and purification of ingredients of interest from our microalgal biomass.
Using a non-GMO strain of Nannochloropsis salina, we have developed a robust, proprietary process that can stably and reproducibly produce an EPA rich lipid extract at scale, a goal that has eluded many companies who had attempted to produce algal EPA from Nannochloropsis. Our integrated cultivation, extraction, and purification process has now yielded an exceptional EPA rich natural algal extract, AlgaLab™ CEPA Natural. Using CEPA Natural, Xiaozao has developed additional proprietary processes that will yield a variety of unique derivative products, including AlgaLab CEPA EE and CEPA EE Ultra EPA ethyl ester oils, and AlgaLab CEPA EE Powder to meet the different needs in food, nutritional supplement and active pharmaceutical intermediate (APIs), to cosmetics and personal care applications.
